Multiple sclerosis greatly impacts family members/partners: Evidence using the Family Reported Outcome Measure (FROM-16)
MS substantially impacts the quality of life of family members/partners of pwMS, indicating a need to assess this impact routinely. The FROM-16 could be used to measure the MS family impact in routine practice to support family members appropriately and to include this impact in health economic appraisal and therapeutic clinical trials.
Authors
- Andrew Yule Finlay (ORCID: https://orcid.org/0000-0003-2143-1646)
- Mark Nixon (ORCID: https://orcid.org/0000-0001-5437-3724)
- John R Ingram (ORCID: https://orcid.org/0000-0002-5257-1142)
- Gillian Ingram (ORCID: https://orcid.org/0000-0001-5898-9462)
- Kennedy Otwombe (ORCID: https://orcid.org/0000-0002-7433-4383)
- Sam Salek (ORCID: https://orcid.org/0000-0002-4612-5699)
- Faraz Mahmood Ali (ORCID: https://orcid.org/0000-0002-4184-2023)
- Rubina Shah (ORCID: https://orcid.org/0000-0001-8158-712X)
- Stuart J Nixon
Institutions
- Swansea Bay University Health Board (GB)
- University of Hertfordshire (GB)
- University of the Witwatersrand (ZA)
- Chris Hani Baragwanath Hospital (ZA)
- Institute of Economic Development (GB)
- Perinatal HIV Research Unit (ZA)
- Cardiff University (GB)
Publication Details
- Journal
- Multiple Sclerosis Journal - Experimental Translational and Clinical
- Published
- 2025-04-01
- DOI
- https://doi.org/10.1177/20552173251338762
- Citations
- 2
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 2.94